Bay Rivers Group Idexx Laboratories Inc Transaction History

Bay Rivers Group

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 05, 2023	SELL	$432.42 - $556.67 $6,053 - $7,793	-14 Reduced 2.18%	628 $274,000
Q1 2023 Apr 18, 2023	SELL	$406.01 - $514.59 $2,842 - $3,602	-7 Reduced 1.08%	642 $321,000
Q2 2022 Jul 12, 2022	SELL	$327.37 - $553.44 $14,076 - $23,797	-43 Reduced 6.21%	649 $228,000
Q1 2022 Apr 20, 2022	SELL	$466.52 - $631.01 $6,531 - $8,834	-14 Reduced 1.98%	692 $379,000
Q4 2021 Jan 20, 2022	BUY	$586.54 - $666.48 $129,625 - $147,292	221 Added 45.57%	706 $465,000
Q3 2021 Oct 13, 2021	BUY	$621.9 - $705.76 $70,274 - $79,750	113 Added 30.38%	485 $302,000
Q2 2021 Jul 14, 2021	BUY	$486.36 - $637.08 $180,925 - $236,993	372 New	372 $235,000

1,208

72.6M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $35.6B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Bay Rivers Group, based on Form 13F filings with the SEC.

Stay updated on Bay Rivers Group with notifications on news.